Azimi, Amirreza <br/><br/>
Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis.  [electronic resource] 

 -  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia  Jan 2020 
 - 129-134 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>1532-2653 
<br/><br/><label>Standard No.: </label>10.1016/j.jocn.2019.08.103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--blood<br/>Female<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Incidence<br/>JC Virus--immunology<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Natalizumab--adverse effects<br/>Seroconversion--drug effects